Hilary Calvert
Advisory Board
Oncology
PIQUR
Switzerland
Biography
Member of the Oncology Advisory Board, has a longstanding interest in cancer drug discovery and development and has been closely involved with the development of Carboplatin®, Raltitrexed®, Pemetrexed® and Rucaparib. He is the Director of Anticancer Drug Discovery and Development and Professor of Cancer Therapeutics at University College London Partners and is based at the UCL Cancer Institute where his role is to foster clinical programs of new drug trials in cancer and drug discovery initiatives.
Research Interest
Oncology cancer drug discovery and development
